Skip to main content
logo
Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.270
+0.070 (3.18%)
Jul 31, 2026, 4:08 PM HKT

HKG:2185 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
44.9344.93----
Revenue Growth
115.38%-----
Gross Profit
18.0218.02----
Operating Income
-71.69-71.69-61.04-164.62-252.2-409.65
Net Income
-70.05-70.05-87.94-175.89-204.24-361.45
Earnings Per Share
-0.29-0.29-0.36-0.72-0.84-1.64
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
248.52248.52202.39369.44451.32708.53
Total Debt
12.7312.738.281.7618.1122.45
Net Cash (Debt)
235.8235.8194.1367.68433.21686.09
Net Cash Growth
-22.74%21.48%-47.21%-15.13%-36.86%51.67%
Net Cash Per Share
0.970.970.801.511.783.11

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-67.67-67.67-118.44-49.03-140.62-88.47
Capital Expenditures
-7.64-7.64-47.14-17.72-30.04-34.27
Free Cash Flow
-75.3-75.3-165.58-66.74-170.65-122.75
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
40.10%40.10%----
Operating Margin
-159.56%-159.56%----
Pretax Margin
-213.66%-213.66%----
Profit Margin
-155.91%-155.91%----
FCF Margin
-167.59%-167.59%----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
11.0528.19----